Bellerophon Therapeutics (NASDAQ:BLPH) Coverage Initiated by Analysts at initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report released on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance Shares of NASDAQ BLPH opened at $0.04 on Friday. The business has a 50-day moving average of $0.31 and a two-hundred […]

Leave a Reply

Your email address will not be published.

Previous post Editorial: New House Speaker on to something with debt commission
Next post CSI Compressco (NASDAQ:CCLP) Research Coverage Started at